The precautionary principle in the pharmaceutical domain: A philosophical enquiry into probabilistic reasoning and risk aversion

Health, Risk and Society

Volumn 15, Issue 2, 2013, Pages 123-143

  Osimani, Barbara ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

precautionary principle; risk; risk analysis; risk management; scientific evidence; uncertainty

Indexed keywords

ACETYLSALICYLIC ACID; CERIVASTATIN; IBUPROFEN; PARACETAMOL; ROFECOXIB; THALIDOMIDE; VALDECOXIB;

ARTICLE; ASTHMA; AVERSION; DECISION MAKING; ENVIRONMENTAL PROTECTION; EPISTEMOLOGY; HUMAN; NONHUMAN; PHARMACEUTICAL DECISION; PHOCOMELIA; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAFETY;

EID: 84876312949     PISSN: 13698575     EISSN: 14698331     Source Type: Journal    
DOI: 10.1080/13698575.2013.771736     Document Type: Article

References (88)

1. Abraham, J. and Davis, C. 2005. Risking public safety: experts, the medical profession and 'acceptable' drug injury. Health, risk & society, 7 (4): 379-395.
2. Abraham, J. and Reed, T. 2001. Trading risks for markets: the international harmonization of pharmaceutical regulation. Health, risk & society, 3 (1): 113-128.
3. Alaszewski, A. and Burgess, A. 2007. Risk, time and reason. Health, risk & society, 9 (4): 349-358.
4. Allmers, H., Skudlik, C. and John, S.M. 2009. Acetaminophen use: a risk for asthma?. Current allergy and asthma reports, 9 (2): 164-167.
5. Amberbir, A. 2011. The role of acetaminophen and geohelminth infection on the incidence of wheeze and eczema: a longitudinal birth-cohort study. American journal of respiratory and critical care medicine, 183 (2): 165-170.
6. Apel, 2002. Are risk assessment and the precautionary principle equivalent? CEI, Competitive Enterprise Institute, June [online]. Available from:. http://cei.org/outreach-regulatory-comments-and-testimony/are-risk-assessment-and-precautionary-principle-equivale-0 (http://cei.org/outreach-regulatory-comments-and-testimony/are-risk-assessment-and-precautionary-principle-equivale-0) (Accessed: 13 May 2011).
7. Barr, R.G. 2004. Prospective study of acetaminophen use and newly diagnosed asthma among women. American journal of respiratory and critical care medicine, 169 (7): 836-841.
8. Beasley, R.W. 2008. ISAAC Phase Three Study Group. Association between acetaminophen use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from phase three of the ISAAC programme. Lancet, 372 (9643), 1039-1048.
9. Beasley, R.W. 2011. ISAAC Phase Three Study Group. Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood phase three. American journal of respiratory and critical care medicine, 183 (2), 171-178.
10. Beck, U. 1986. Risikogesellschaft-auf dem weg in eine andere moderne, Berlin: Suhrkamp.
11. Birnie, P.W. and Boyle, A. 2002. International law and the environment, Oxford: Oxford University Press.
12. Bodansky, D. 1994. " The precautionary principle in U.S. environmental law ". In Interpreting the precautionary principle, Edited by: O'Riordan, T. and Cameron, J. London: Earthscan Publications, 203-228. In
13. Burgess, A. 2004. Cambridge: Cambridge University Press. Cellular phones, public fears, and a culture of precaution,
14. Burgess, A. 2011. Scared to death. From BSE to global warming: why scares are costing us the earth. Health, risk & society, 13: 711-712. 7-8:
15. Cameron, J. 1999. " The precautionary principle ". In Trade, environment and the millennium, Edited by: Sampson, G. and Chambers, W. 240-269. Tokyo: United Nations University Press. In
16. Cartwright, N. 1989. Nature's capacities and their measurement, Oxford University Press. Oxford:
17. Cartwright, N. 2007. Are RCTs the gold standard?. BioSocieties, 2: 11-20.
18. Cook, T.D. 1979. Quasi-experimentation: design and anlysis issues for field settings, and Campbell, D.T., Boston, MA: Houghton Mifflin Company.
19. Dettling, H.-U. 2005. Arzneimittelrecht als Sicherheitsrecht-Zugleich ein Beitrag zur Rechtfertigung von Freiheitsbeschränkungen. PharmRecht, 4, 162-173.
20. Di Fabio, U. 1994. Risikoentscheidungen im rechtsstaat: zum wandel der dogmatik im öffentlichen recht, insbesondere am beispiel der arzneimittelüberwachung, Tübingen: Mohr.
21. Dupuy, J.P., 2004. Complexity and uncertainty a prudential approach to nanotechnology. European Commission, A Preliminary Risk Analysis on the Basis of a Workshop Organized by the Health and Consumer. Protection Directorate General of the European Commission, Brussels 1-2 March 2004. http://europa.eu.int/comm/health/ph_risk/documents/ev_20040301_en.pdf (http://europa.eu.int/comm/health/ph_risk/documents/ev_20040301_en.pdf) (Accessed: 24 June 2011).
22. Eneli, I. 2005. Acetaminophen and the risk of asthma: the epidemiologic and pathophysiologic evidence. CEST, 127 (2): 604-612.
23. Erev, I., Ert, E. and Yechiam, E.,. 2008. Loss aversion, diminishing sensitivity, and the effect of experience on repeated decisions. Journal of behavioral decision making, 21: 575-597.
24. Ert, E. and Erev, I. 2008. The rejection of attractive gambles, loss aversion, and the lemon avoidance heuristic. Journal of economic psychology, 29: 715-723.
25. Fisher, E. 2002. Precaution, precaution everywhere: developing a 'common understanding' of the precautionary principle in the European Union. Maastricht journal of European and comparative law, 9 (1): 7-28.
26. Foster, K.R., Vecchia, P. and Repacholi, M.H. 2000. Risk management: science and the precautionary principle. Science, 288 (5468): 979-981.
27. Francke, R. and Hart, D. 1999. Charta der Patientenrechte. Nomos: Baden-Baden,
28. Hacking, I. 1986. " Culpable ignorance of interfernce effects ". In Value at risk, Edited by: MacLean, D. 136-154. Totowa, NJ: Rowman&Allanheld. In
29. Hacking, I. 2001. An introduction to probability and inductive logic. Cambridge: Cambridge University Press.,
30. Hansson, S.O. 1997. The limits of precaution. Foundations of science, 2: 293-306.
31. Harremoës, P.D., ed. 2002. The precautionary principle in the 20th century: late lessons learnt from early warnings, London: Earthscan.
32. Hart, D. 1998. " Zum management von Arzneimittelrisikendurch Ärzte und Unternehmen-Rechtsverfassung, Sozio-Psychologie, Empirie ". In Risikoanalysen: Über den UmgangmitGesundheits- und Umweltgefahren, Edited by: Preuss, V. Vol II, Heidelberg: Roland Asanger. In
33. Heyman, B. 2010. Risk, safety, and clinical practice: healthcare through the lens of risk, Oxford: Oxford University Press.
34. Howick, J. 2011. The philosophy of evidence-based medicine, Oxford: Wiley-Blackwell.
35. Howson, C., and Urbach, P. 1993. Scientific reasoning: the Bayesian approach, Illinois: Open Court.
36. Jensen, K.K. 2002. The moral foundation of the precautionary principle. Journal of agricultural and environmental ethics, 15: 39-52.
37. Johnson, C.C., and Ownby, D.R. 2011. Have the efforts to prevent aspirin-related Reye's syndrome fuelled an increase in asthma?. Clinical experimental allergy, 42 (3): 296-298.
38. Jonas, H. 1984. The imperative of responsibility, Chicago, IL: The University of Chicago Press. Orig. tit. Das Prinzip Verantwortung: Versuch einer Ethik für die technologische Zivilisation. Frankfurt am Main: Suhrkamp, 1979.
39. Jüni, P. 2004. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet, 364 (9450), 2021-2029.
40. Kahneman, D., Knetsch, J.L. and Thaler, R.H.,. 1991. Anomalies: the endowment effect, loss aversion, and status quo bias. The journal of economic perspectives, 5 (1): 193-206.) (Winter, 1991),
41. Kahneman, D., and Tversky, A. 1984. Choices, values and frames. American psychologist, 39: 341-350.
42. Karimi, M. 2006. Acetaminophen use and the symptoms of asthma, allergic rhinitis and eczema in children. Iran journal of allergy asthma and immunology, 5 (2): 63-67. Mirzaei, M., and Ahmadieh, M.H.
43. Kermer, D.A. 2006. Loss aversion is an affective forecasting error. Psychological science, 17: 649-653.
44. Knetsch, J.L. 1989. The endowment effect and evidence of nonreversible indifference curves. American economic review, 79: 1277-1284.
45. Kriebel, D. 2001. The precautionary principle in environmental science. Environmental health perspectives, 109 (9): 871-876.
46. Kyburg, H.E. 2001. Uncertain inference. Cambridge: Cambridge University Press., and Man Teng, C.,
47. Lesko, S.M. 2002. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics, 109 (2) et al,)http://www.//pediatrics.aappublications.org/content/109/2/e20.full.pdf+html
48. Marrani, D. 2008. La Comunità europea e le nanotecnologie: verso la negazione del principio di precauzione?. In: L. Marini and L. Palazzani, eds. Il principio di precauzione tra filosofia, biodiritto e biopolitica. Roma: Edizioni Studium.,
49. Matuzzi, M. 2003. Scienceand policy making in environment and health: role of the precautionary principle. Epidemiology, 14 (5): 522-530.
50. McBride, J.T. 2011. The association of acetaminophen and asthma prevalence and severity. Pediatrics, 128 Available from: http://pediatrics.aappublications.org/content/128/6/1181.full.pdf + html?sid=29b845ce-0023-48dd-9835-3c87a6b45b69 [Accessed 2 July 2012].
51. McDonald, J. 2006. " Tr(e)ading cautiously: precaution in WTO decision making ". In Implementing the precautionary principle: perspectives and prospects, Edited by: Fisher, E., Jones, J.S. and von Schomberg, R. 160-181. Cheltenham: Edward Elgar Publishing.
52. Miller, H.I., and Conko, G. 2000. " Genetically modified fear and the international regulation of biotechnology ". In Rethinking risk and the precautionary principle, Edited by: Morris, J. Oxford: Butterworth-Heinemann, 84-104. In
53. Morris, J. 2000. Rethinking risk and the precautionary principle, Oxford: Butterworth and Heinemann.
54. Newson, R.B. 2000. Paracetamol sales and atopic diseases in children and adults: an ecological analysis. European respiratory journal, 16 (5): 817-823.
55. Osimani, B., 2007. Probabilistic information and decision-making in the health context: package leaflets as basis for informed consent. Thesis (PhD). University of Lugano.
56. Osimani, B. 2010. Pharmaceutical risk communication: sources of uncertainty and legal tool of uncertainty management. Health risk and society, 12 (5): 453-469.
57. Osimani, B. 2013a. Lower level" evidence for pharmaceutical harm assessment: methodological concerns and epistemological rationales. Preventive medicine, forthcoming.,
58. Osimani, B. 2013b. Until RCT-proven? On the asymmetry of evidence requirements for risk assessment. Journal of evaluation in clinical practice, forthcoming.,
59. Osimani, B., Russo, F. and Williamson, J. 2011. Scientific evidence and the law: an objective Bayesian formalisation of the precautionary principle in pharmaceutical regulation. Journal of philosophy, science and law, 11 http://www.//www6.miami.edu/ethics/jpsl/archives/all/BayesianFormalization.html [Accessed 25 March 2012].
60. Papanikolaou, P.N., Christidi, G.D. and Ioannidis, J.P.A. 2006. Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. Canadian medical association journal, 174 (5): 635-641.
61. Papineau, D. 1994. The virtues of randomization. The British journal for the philosophy of science, 45 (2): 437-450.
62. Peterson, M. 2006. The precautionary principle is incoherent. Risk analysis, 26 (3): 595-601.
63. Psaty, B. 2008. Opportunities for enhancing the FDA guidance on pharmacovigilance. JAMA, 300 (8), 952-953.and Vandenbroucke, J.P.,
64. Raffensperger, C., and Tickner, J., eds. 1999. Protecting public health and the environment: implementing the precautionary principle, Washington, DC: Island Press.
65. The Royal Society, Risk: analysis, perception and management. London: The Royal Society, Report of a Royal Society Study Group 1992
66. Sackett, D.L. 2000. Evidence-based medicine: how to practice and teach EBM, 2nd, Edinburgh: Churhill Livingstone.
67. Sanden, J. 2006. Das Vorsorgeprinzip im europäischen und deutschen Umweltrecht: Weiterentwicklung und Impulse für das internationale Recht. Osaka university law review, 53: 243-270. Available from OUKA (Osaka University Knowledge Archive): http://ir.library.osaka-u.ac.jp/dspace/bitstream/11094/4047/1/oulr053-243.pdf[Accessed 8 December 2012].
68. Sandin, P. 2004. Precautionary defaults: a new strategy for chemical risk management. Human and risk assessment, 10 (1): 1-18.
69. Sandin, P. 2007. " Common-sense precaution and varieties of the precautionary principle ". In Risk: philosophical perspectives, Edited by: Lewens, T. London: Routledge, 99-112. In
70. Sandin, P. 2002. Five charges against the precautionary principle. Journal of risk research, 5 (4): 287-299.
71. Santoro, M. 2005. Charting a sustainable path for the twenty-first century pharmaceutical industry. In: M.A. Santoro and T.M. Gorrie, eds. Ethics and the pharmaceutical industry. Cambridge: CUP.,
72. Scheu, G. 2003. In Dubio Pro Securitate: Contergan, Hepatitis-/AIDS-Blutprodukte, Spongiformer Humaner Wahn und kein Ende? Grundrechtliche Gefahrenvorsorge für Leib und Leben im Recht der Produkt- und Arzneimittelsicherheit-auch unter Aspekten der Europäisierung und Globalisierung, Nomos: Baden-Baden.
73. Seaton, A., Godden, D.J. and Brown, K. 1994. Increase in Asthma: a more toxic environment or a more susceptible population?. Thorax, 49: 171-174.
74. Shaheen, S. 2008. Selenium and Asthma Research Integration Project; GA2LEN. The relation between paracetamol use and asthma: a GA2LEN European case-control study. European respiratory journal, 32 (5): 1231-1236.
75. Slovic, P. The perception of risk. London: Earthscan., 2000
76. Stricker, B., and Psaty, B. 2004. Detection, verification, and quantification of adverse drug reactions. British medical journal, 329: 44-47.
77. Sunstein, C.R. 2005. Laws of fear: beyond the precautionary principle, Cambridge: Cambridge University Press.
78. Tallacchini, M.C. 2005. Before and beyond the precautionary principle: epistemology of uncertainty in science and law. Toxicology and applied pharmacology, 207: 645-651.
79. Tallacchini, M.C. 2008. " Epistemologie dell'ignoto, politica e diritto ". In Il principio di precauzione tra filosofia e biopolitica, Edited by: Marini, L. and Palazzani, L. Rome: EdizioniStudium, 99-109. In
80. UNCED. 1993. The earth summit: the United Nations conference on environment and development (1992: Rio de Janeiro), Introduction and commentary by S. P. Johnson, London: Graham and Trotman.
81. Vandenbroucke, J.P. 2004. When are observational studies as credible as randomized trials?. Lancet, 363: 1728-1731.
82. Vandenbroucke, J.P. 2006. What is the best evidence for determining harms of medical treatment? Commentary. Canadian medical association journal, 174 (5): 645-646.
83. Vandenbroucke, J.P. 2007. Letter to the editor. JAMA, 297 (19): 2077-2078.
84. Vandenbroucke, J.P. 2008. Observational research, randomised trials, and two views of medical science. PLoS medicine, 5 (3): 339-343. (quotation in the text are from the longer version: 1-28).
85. Vandenbroucke, J.P., and Psaty, B.M. 2008. Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects. JAMA, 300 (20): 2417-2419.
86. Worral, J. 2007a. Evidence in medicine and evidence-based medicine. Philosophy compass, 2 (6): 981-1022.
87. Worral, J. 2007b. Why there's no cause to randomize. British journal for the philosophy of science, 58: 451-488.
88. Yechiam, E., and Ert, E. 2007. Evaluating the reliance on past choices in adaptive learning models. Journal of mathematical psychology, 52: 75-84.